---

Pascal Soriot

Executive Director and Chief Executive Officer, AstraZeneca

While at Roche, Soriot was in charge of integrating Genentech, the Californian biotech company, after a $47 billion takeover. He also led AstraZenica in a successful defense against acquisition by Pfizer in 2014 – a feat few envisaged before he took the reins. Soriot worked as a vet before embarking on his career in business.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016